Conference Events

ENDO 2019 is jam-packed with sessions to keep you up-to-date with clinical and scientific advances in endocrinology; and thanks to the Endocrine Society’s Continuing Medical Education Services (CMES) and Special Programs Committee (SPC) there are even more opportunities to hear from the experts with Conference Events.

Conference Events are certified by the Endocrine Society and are planned and conducted under the supervision of the SPC in strict compliance with the Essential Standards & Guidelines of the Accreditation Council for Continuing Medical Education (ACCME).

There is no cost to attend and all ENDO 2019 attendees are welcome; however, seating is limited and advance registration is recommended. Complimentary breakfast or dinner will be provided. Tickets will not be issued this year, so arrive early as seating is done on a first-come, first-served basis. While available seating cannot be guaranteed, we will make every effort to accommodate you.

Register for Conference Events when you register for ENDO 2019 or add an event to an existing ENDO registration.

Saturday, March 23, 2019

Patient-Centered Approaches to Long-Term Success in Weight Loss (6:45 PM–9:15PM)
Program Chair: W. Troy Donahoo, MD—University of Florida
CME/MOC: 2.00

Learning Objectives—Upon completing this activity, learners will better be able to:

  • Recognize obesity as a disease and assess patients for obesity and its comorbidities
  • Apply evidence-based guidelines in the selection and use of pharmacotherapy to treat patients with obesity
  • Assess patient-centered strategies to overcome challenges in long-term successful weight loss maintenance with lifestyle interventions.

The Endocrine Society thanks Novo Nordisk for supporting this program.


A Patient Centered Approach to Hypophosphatemia: Diagnosis, Evaluation, and Treatment (6:45 PM–9:15PM)
Program Chair: Anda Raluca Gonciulea, MD—Yale New Haven Northeast Medical Group
CME/MOC: 2.00

Learning Objectives—Upon completing this activity, learners will be able to:

  • Incorporate best practices for evaluating and diagnosing patients with hypophosphatemia in their practice
  • Discuss pathophysiology and treatment strategies for patients with FGF-23 mediated phosphate disorders
  • Discuss pathophysiology and treatment strategies for patients with non-FGF-23 mediated phosphate disorders

The Endocrine Society thanks Ultragenyx Pharmaceutical for supporting this program.


Sunday, March 24, 2019

Clinical Advances in Adult Growth Hormone Deficiency: Delivering Patient-Centered Care to Improve Outcomes (5:45 PM–8:15 PM)
Program Chair: Beverly MK Biller, MD—Harvard Medical School
CME/MOC: 2.00

Learning Objectives—Upon completing this activity, learners will better be able to:

  • Identify key clinical components, including recent advances, that inform the differential diagnosis of GHD in adult patients
  • Evaluate the clinical necessity, efficacy, and safety of rhGH therapy as a treatment strategy for adult GHD
  • Recommend individualized dosing and monitoring strategies for adults using growth hormone therapy
  • Incorporate practical strategies to address barriers to rhGH therapy adherence and improve the delivery of patient centered-care for adult patients with GHD

The Endocrine Society thanks Novo Nordisk for supporting this program.


Unraveling the Genetics of Obesity: An Update on Rare Causes and Emerging Options for Severe Obesity Across the Lifespan (5:45 PM–8:15 PM)
Program Chair: Jennifer Lynne Miller, MD—University of Florida
This program is a non-CME program. Participants will not receive CME credit for attending.

Learning Objectives—Upon completing this activity, learners will better be able to:

  • Understand the evidence for the management of treating children and adolescents with obesity
  • Review the role of medications and surgery for weight loss in a pediatric population and long-term outcomes
  • Are there lessons to be learned from the adult population

The Endocrine Society thanks Rhythm Pharmaceuticals for supporting this program.